Incyte Tech Stack

Oncology and immunology-focused biopharmaceutical company with internal drug discovery

Pharmaceutical Manufacturing Wilmington, Delaware 1,001–5,000 employees Public Company

Incyte is a mid-sized pharma company with 2,600+ employees and a portfolio of first-in-class medicines in oncology and inflammation. The tech stack reveals a clinical-stage company: SAP and PeopleSoft for ERP, Veeva for regulatory/quality workflows, IQVIA for market intelligence, and cloud compute (AWS, SageMaker, Python, TensorFlow) for data modeling — typical for post-discovery, pre-commercialization biotech. Sales and healthcare hiring dominate (39 and 29 roles respectively) while research stays lean (14 roles), signaling a shift from discovery toward commercial execution. Active projects center on launch strategy, market access, and medical affairs — consistent with a company moving molecules from clinic to market.

Tech Stack 24 technologies

Core StackAWS AWS Lambda SageMaker Python TensorFlow PyTorch SAP SAS Power BI Tableau Salesforce CDISC Qlik Veeva Excel RPA Microsoft Office Teams Prism Outlook PowerPoint Word PeopleSoft IQVIA

What Incyte Is Building

◆Challenges

Patient access
Complex access and fulfillment processes
Access challenges
Launching first-in-class product
Product access
Ensuring compliance with industry standards
Aggressive launch targets
Launching new medications
Reimbursement issues
Meeting revenue targets

▲Active Projects

Regional launch strategy for new hs therapy
Access & fulfillment
Advisory board planning and execution
Key account management
Speakers bureau development
Investigator-initiated research program
Ruxolitinib medical affairs program strategy
Process improvement initiatives for inventory transactions
Medical pre-launch and launch strategy
Publication strategy

Hiring Activity

Steady140 roles · 55 in 30d

Department

Sales

Healthcare

Research

Marketing

Manufacturing

Ops

Data

Seniority

Senior

Director

Mid

Manager

Principal

Junior

Intern

Lead

Notable leadership hires: Medical Director, Oncology Business Director, Compensation Lead, Dermatology Director, Area Sales Director

Company intelligence

Find more companies like Incyte by tech stack, pain points and active projects

Get started free

About Incyte

Incyte discovers, develops, and commercializes medicines for oncology and autoimmune disease, with a focus on targeted therapies and immuno-oncology. Founded in 2002, the company has built a portfolio where the majority of clinical candidates were discovered internally, giving it differentiated IP. Operations span North America, Europe, and Asia. The pain-point pattern — patient access, reimbursement, complex fulfillment, aggressive launch targets — reflects the operational reality of bringing first-in-class products to market: regulatory pathways are narrow, payer coverage is uncertain, and distribution logistics are unique to each therapy and geography.

HeadquartersWilmington, Delaware

Company Size1,001–5,000 employees

Hiring MarketsUnited States, France, Germany, Japan, Switzerland, Australia, Canada, Austria

Frequently Asked Questions

What tech stack does Incyte use?

Incyte runs SAP and PeopleSoft for core operations, Veeva for regulatory and quality, Salesforce for CRM, AWS and SageMaker for data science, and SAS/Python/TensorFlow for analytics. BI tools include Tableau, Power BI, and Qlik.

Where does Incyte have operations?

Headquartered in Wilmington, Delaware with 2,600+ employees. Active hiring in the United States, France, Germany, Japan, Switzerland, Australia, Canada, and Austria.